People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eclipse Bioinnovations, Inc. | — | Biotechnology | Series A | $16.9M | $13.4M | 2025 |
| aMBR Genomics, Inc. | — | Biotech | Seed | $1.1M | $2.6M | 2025 |
Eugene Yeo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eugene Yeo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Chu | 1 | 3 |
| Michael Moser | 1 | 1 |
| Daniel Vasella | 1 | 1 |
| Edmond Wong | 1 | 1 |
| Daniel L Vasella | 1 | 1 |
| Eric L Van Nostrand | 1 | 1 |
| Hallie L Kuhn | 1 | 1 |
| Ahna Skop | 1 | 1 |
| Eugene W Yeo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.